Home > Press > Strem Chemicals and SONA Nanotech Sign Distribution Agreement for the World’s First Gold Nanorods Synthesized without CTAB
Abstract:
Strem Chemicals, Inc., a manufacturer of specialty chemicals for research and development, and SONA Nanotech Ltd. (SONA), a manufacturer of gold nanoparticles, today announced the signing of a distribution agreement.
This agreement will make Strem Chemicals the first global distributor of gold nanorods (GNRs) completely synthesized without CTAB. SONA is the first company in the world to be able to synthesize and stabilize high quality gold nanorods without the use of CTAB.
“Over the last 30 years, there has been incredible progress within the research community working with gold nanoparticles in the areas of photothermal cancer treatment, diagnostic imaging, drug delivery and other areas. CTAB is a major concern in advancing the existing research into human use,” stated Dr. Ephraim Honig, COO of Strem Chemicals. “We are excited to be the first to bring to market gold nanoparticles that can help bring decades of research closer to the reality of life changing procedures.”
SONA CEO, Dr. Gerrard Marangoni, says, “This is a very important announcement for SONA and the gold nanoparticles industry globally. Our ability to manufacture gold nanorods without CTAB/CTA+ will accelerate the adoption of these nanoparticle products for medical and surgical applications. In addition, our GNR products offer many features, supported by our patent-pending technical advances, that will offer benefits to the primary commercial users of gold nanoparticle products, biotech companies, who make gold Nano rod-enabled point-of-care, point-of-use and In-Vitro diagnostic test kit products.”
####
About Strem Chemicals, Inc.
Strem Chemicals, Inc., established in 1964, is a privately held manufacturer and marketer of specialty chemicals of high purity. Strem’s key products include catalysts, ligands, organometallics, metal carbonyls and nanomaterials. Its products are used for research and development and commercial scale applications, especially in the pharmaceutical, microelectronics, chemicals and petrochemicals industries. Strem Chemicals also provides custom synthesis, process development and cGMP manufacturing services.
About SONA Nanotech Ltd.
Sona Nanotech Ltd. manufacturers the Gemini™ and Omni™ Gold Nanorod (GNR) product lines - the world's first and only CTAB-FREE, bio-friendly GNR products. The technical advances of our patent-pending GNR technology offers researchers and product manufacturers a suite of features and benefits which make our products ideally suited to In-Vivo medical applications and the manufacture of GNR-enabled diagnostic point-of-care, point-of-use, and In-Vitro test products. Sona welcomes collaborating with partners to create shared intellectual property resulting in market leading GNR-enabled products and medical treatment solutions.
For more information, please click here
Contacts:
Ashley Bianco
Associate Marketing Specialist
Strem Chemicals, Inc.
Phone: 978-499-1672
Strem Chemicals, Inc.
7 Mulliken Way
Newburyport MA 01950-4098
USA
Strem Chemicals, Inc
15, rue de l'Atome
Zone Industrielle
67800 BISCHHEIM France
Strem Chemicals, Inc.
Postfach 1215
77672 KEHL
Germany
Strem Chemicals UK Ltd
An Independent Distributor of Strem Chemicals products
Newton Hall
Town Street
Newton
Cambridge, CB22 7ZE, UK
Copyright © Strem Chemicals, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||